IOL Chemicals and Pharmaceuticals Limited

BSE:524164 Stock Report

Market Cap: ₹24.0b

IOL Chemicals and Pharmaceuticals Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure9.3yrs
Board average tenure3yrs

Recent management updates

Recent updates


CEO

IOL Chemicals and Pharmaceuticals has no CEO, or we have no data on them.


Leadership Team

NamePositionTenureCompensationOwnership
Pardeep Khanna
Chief Financial Officer9.3yrs₹15.80mno data
Abhay Singh
VP, Company Secretary & Compliance Officer5.1yrs₹7.40mno data
Varinder Gupta
MD & Whole Time Director17.3yrs₹98.57m2.04%
₹ 489.9m
Vikas Gupta
Joint Managing Director & Executive Director9.6yrs₹30.06mno data
Kushal Rana
Director of Works & Wholetime Directorno data₹17.07mno data
Abhiraj Gupta
Executive Director1.7yrs₹12.99mno data
Gurupur Pai
Chief Technology Officerno datano datano data
Damandeep Singh
President of Projectno data₹780.00kno data
Kamlesh Ranbhan
President of R&Dno datano datano data
Gopal Singla
President of Engineeringno datano datano data
Praveen Hans
President of API Businessno datano datano data

9.3yrs

Average Tenure

54yo

Average Age

Experienced Management: 524164's management team is seasoned and experienced (9.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Varinder Gupta
MD & Whole Time Director18.5yrs₹98.57m2.04%
₹ 489.9m
Vikas Gupta
Joint Managing Director & Executive Director1.7yrs₹30.06mno data
Kushal Rana
Director of Works & Wholetime Director3.5yrs₹17.07mno data
Abhiraj Gupta
Executive Director1.7yrs₹12.99mno data
Rajender Malla
Independent Chairman of the Board5.8yrs₹500.00kno data
Sharad Tyagi
Additional Independent Director2.6yrs₹1.15mno data
Harpal Singh
Independent Director5.8yrs₹750.00kno data
Rajni Jha
Independent Directorless than a yearno datano data

3.0yrs

Average Tenure

62.5yo

Average Age

Experienced Board: 524164's board of directors are considered experienced (3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 22:22
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

IOL Chemicals and Pharmaceuticals Limited is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullAntique Stockbroking Ltd.
Rohit BhatBatlivala & Karani Securities India Pvt. Ltd.
Kameswari V. S. ChavaliFirstCall Research